BBO-11818 in Adult Subjects With KRAS Mutant Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Eli Lilly and Company
Eli Lilly and Company
Incyte Corporation
AstraZeneca
BeiGene
Checkpoint Therapeutics, Inc.
Taiho Pharmaceutical Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Canadian Cancer Trials Group
Nektar Therapeutics
Eli Lilly and Company
AbbVie
University of California, San Diego
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
University Hospital of Crete
Providence Health & Services